Please check your internet connection and try again.
# Clobazam (Oral Formulation)
## Overview
Clobazam is a benzodiazepine derivative with anticonvulsant properties. It is thought to exert its effects by enhancing the activity of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA).
## Primary Indications
* Adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age and older.
* Off-label uses include other seizure types and anxiety disorders.
## Adult Dosing
* **Lennox-Gastaut Syndrome:** Initial dose is typically 5 mg twice daily. Dose can be increased by 5-10 mg every week.
* **Maintenance:** Usual maintenance dose is 10-20 mg twice daily, with a maximum recommended dose of 40 mg daily.
* **Titration:** Doses should be titrated slowly to minimize adverse effects.
## Pediatric Dosing
* **Lennox-Gastaut Syndrome (2 years and older):**
* Initial dose: 5 mg twice daily.
* Maintenance dose: Typically 10-20 mg twice daily.
* Maximum recommended dose: 40 mg daily.
* Dosing should be individualized based on response and tolerability.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. No specific dose reduction guidelines are established, but may require lower doses and slower titration.
* **Renal Impairment:** Use with caution. No specific dose reduction guidelines are established, but may require lower doses and slower titration.
## Contraindications
* Known hypersensitivity to clobazam or other benzodiazepines.
## Adverse Effects
Common adverse effects include somnolence, decreased appetite, constipation, ataxia, fatigue, aggression, irritability, and behavioral changes.
Serious adverse effects include:
* **Serious Skin Reactions:** Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been reported.
* **Suicidal Behavior and Ideation:** Antiepileptic drugs, including clobazam, may increase the risk of suicidal thoughts and behavior.
* **Abuse and Dependence:** As with other benzodiazepines, clobazam has the potential for abuse and dependence.
* **Respiratory Depression:** Especially when used in combination with other CNS depressants.
* **Withdrawal Symptoms:** Abrupt discontinuation may lead to withdrawal symptoms.
## Key Drug Interactions
* **CNS Depressants (e.g., alcohol, opioids, other benzodiazepines):** Additive sedative effects and increased risk of respiratory depression.
* **CYP3A4 Inhibitors/Inducers:** Clobazam is metabolized by CYP2C19 and CYP3A4. Inhibitors of CYP2C19 (e.g., fluconazole) may increase clobazam levels. Inducers of CYP3A4 may decrease clobazam levels.
* **Antiepileptic Drugs:** Monitor for additive CNS depression and potential changes in seizure control.
## Monitoring
* Monitor for efficacy (seizure frequency reduction).
* Monitor for adverse effects, including somnolence, behavioral changes, and signs of serious skin reactions.
* Monitor for signs of withdrawal if dose is reduced or discontinued.
* Monitor for suicidal behavior and ideation.
## Clinical Pearls
* Clobazam should be initiated at a low dose and titrated slowly, particularly in children and the elderly, to minimize sedation and other CNS side effects.
* Discontinuation should be gradual to avoid withdrawal symptoms.
* Due to the risk of somnolence, patients should be advised to avoid operating heavy machinery or driving until they know how clobazam affects them.
* Clobazam can be taken with or without food.
* Oral suspension should be stored at room temperature and protected from light.
***
*This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult with a qualified healthcare provider for any questions you may have regarding a medical condition or treatment. Prescribing information can change; always refer to the most current official prescribing information for clobazam before making clinical decisions.*
